As of October 2024, Medifron DBT has a market cap of $48.02M. This makes Medifron DBT the world's 25435th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $56.56M | 47.51% |
2023 | $38.34M | -14.52% |
2022 | $44.86M | -55.51% |
2021 | $100.83M | -65.11% |
2018 | $289.04M | 36.21% |
2017 | $212.19M | 26.27% |
2016 | $168.05M | 27.59% |
2015 | $131.71M | 37.82% |
2014 | $95.57M | -19.20% |
2013 | $118.28M | -14.85% |
2012 | $138.91M | - |